Dr | Team Head+ 61 7 3845-3907
Dr Nakamura is a cancer immunologist, leading the Immune Targeting in Blood Cancers Laboratory at QIMR Berghofer Medical Research Institute. He has received clinical training at Department of Haematology and Rheumatology, Tohoku University Hospital, Sendai, Japan. After he obtained his PhD in Medicine, he moved to QIMR Berghofer in 2015 to work on cancer immunology. His research has been focused on understanding the interplay between immune cells and cancer cells to find a way to harness immune-mediated control in haematological malignancies. His research has been supported by project grants from Cure Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme, the National Health and Medical Research Council of Australia, and the Leukaemia Foundation.
2020-current: Team Head, Immune Targeting in Blood Cancers Laboratory
2019-current: Adjunct Associate Professor, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology
2019-current: Honorary Fellow. School of Biomedical Sciences, University of Queensland
2018-2020: Senior Research Officer, QIMR Berghofer Medical Research Institute
2015-2018: Research Officer, QIMR Berghofer Medical Research Institute
2015-2015: Research Associate, Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan
The immune system plays an important role for long-term disease control in haematological malignancies such as multiple myeloma, B-cell lymphoma, and leukaemia. However, in many patients, tumor cells eventually escape the immune system, leading to relapse. Dr Nakamura’s research aims to understand mechanisms of immune escape, and to develop new therapeutic approaches.
2018- current: Australian Society for Medical Research
2018-current: Japanese Cancer Association
2016- current: Australasian Society for Immunology
2012-current: Japanese Society for Immunology
2011-current: Japanese College of Rheumatology
2008-current: Japanese Society of Internal Medicine